Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 3 | 2 | — | — | — | 3 |
Preleukemia | D011289 | — | — | 3 | 2 | — | — | — | 3 |
Myeloid leukemia acute | D015470 | — | C92.0 | 2 | 1 | — | — | — | 2 |
Syndrome | D013577 | — | — | 2 | 1 | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | — | — | — | 1 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | 1 | — | — | — | 1 |
Colorectal neoplasms | D015179 | — | — | 1 | 1 | — | — | — | 1 |
Multiple myeloma | D009101 | — | C90.0 | 1 | 1 | — | — | — | 1 |
Plasma cell neoplasms | D054219 | — | — | 1 | 1 | — | — | — | 1 |
Drug common name | ELTANEXOR |
INN | eltanexor |
Description | Eltanexor is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target exportin-1. |
Classification | Small molecule |
Drug class | exportin 1 inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NC(=O)/C(=C/n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)c1cncnc1 |
PDB | — |
CAS-ID | 1642300-52-4 |
RxCUI | — |
ChEMBL ID | CHEMBL4297623 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB16153 |
UNII ID | Q59IQJ9NTK (ChemIDplus, GSRS) |